|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 159.50 ARS | +0.63% |
|
+3.57% | -33.68% |
| Market Cap | 6.79B 4.56M 3.96M 3.69M 3.39M 6.4M 435M 6.5M 43.5M 17.07M 217M 17.13M 16.75M 727M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 7.53B 5.06M 4.4M 4.09M 3.76M 7.09M 483M 7.2M 48.22M 18.93M 240M 18.99M 18.57M 806M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.63% | ||
| 1 week | +3.57% | ||
| 1 month | -2.15% | ||
| 3 months | -3.33% | ||
| 6 months | -26.50% | ||
| Current year | -33.68% |
| 1 week | 155 | 165 | |
| 1 month | 150 | 165 | |
| Current year | 128.5 | 260 | |
| 1 year | 116 | 357 | |
| 3 years | 21 | 450 | |
| 5 years | 9.1 | 450 | |
| 10 years | 4.2 | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 30/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.63% | +3.57% | -31.25% | +608.89% | 4.56M | ||
| +1.66% | +2.57% | -47.56% | -57.53% | 32.4B | ||
| -0.34% | +5.86% | +91.23% | +124.81% | 13.17B | ||
| +0.48% | +5.65% | -15.72% | +0.96% | 3.84B | ||
| -1.17% | +1.66% | -0.74% | +22.50% | 3.25B | ||
| +7.85% | +12.96% | +48.36% | +23.56% | 2.04B | ||
| -1.45% | +0.74% | +2.10% | +20.14% | 1.89B | ||
| -0.33% | +6.74% | +39.14% | +144.48% | 1.47B | ||
| +1.73% | +9.59% | -20.13% | -8.98% | 1.14B | ||
| +1.24% | +4.31% | -13.95% | -45.82% | 989M | ||
| Average | +1.03% | +4.51% | +5.15% | +83.30% | 6.02B | |
| Weighted average by Cap. | +1.05% | +3.81% | -4.63% | +1.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.56M 4.83M 4.5M 4.13M 7.79M 530M 7.91M 52.99M 20.8M 264M 20.86M 20.41M 885M | 6.4B 4.3M 3.74M 3.48M 3.19M 6.03M 410M 6.12M 41M 16.09M 204M 16.15M 15.79M 685M |
| Net income | -1.42B -952K -827K -770K -707K -1.33M -90.83M -1.36M -9.08M -3.56M -45.22M -3.57M -3.5M -152M | -4.6B -3.09M -2.68M -2.5M -2.29M -4.33M -295M -4.4M -29.44M -11.55M -147M -11.59M -11.34M -492M |
| Net Debt | 863M 580K 504K 469K 431K 813K 55.32M 826K 5.53M 2.17M 27.54M 2.18M 2.13M 92.35M | 738M 495K 431K 401K 368K 695K 47.28M 706K 4.72M 1.85M 23.54M 1.86M 1.82M 78.93M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | ARS 159.50 | +0.63% | 42,815 |
| 30/07/26 | ARS 158.50 | -1.55% | 30,015 |
| 29/07/26 | ARS 161.00 | -0.62% | 17,362 |
| 28/07/26 | ARS 162.00 | +1.57% | 408 |
| 27/07/26 | ARS 159.50 | +3.57% | 4,531 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
















